Vitamin D supplementation for tuberculosis prevention: A meta-analysis
Biomolecules and Biomedicine · 02.07.2025 · 26 (4) · 559-571
DOI: 10.17305/bb.2025.12527 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 02.07.2025. Verfasst von Sheng Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Second Department of Infection, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, Fujian Province, China. Hauptthemen laut MEDLINE: Vitamin D, Dietary Supplements, Tuberculosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vitamin D plays an important role in immune regulation, prompting interest in its potential for preventing tuberculosis. However, clinical findings regarding its protective effects against tuberculosis infection and disease remain inconsistent. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the impact of vitamin D supplementation on the prevention of tuberculosis infection and the progression to active tuberculosis. We searched PubMed, Embase, Cochrane Library, and Web of Science databases through January 2025. Eligible studies involved participants without active tuberculosis at baseline and reported outcomes related to tuberculosis. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup and sensitivity analyses were conducted, and the certainty of evidence was evaluated using the GRADE approach. Six RCTs, involving 15,677 participants, met our inclusion criteria. Compared to placebo, vitamin D supplementation did not significantly reduce the risk of tuberculosis infection (5 RCTs; OR: 0.95; 95% CI: 0.79–1.14; p = 0.55) or the development of active tuberculosis (4 RCTs; OR: 0.77; 95% CI: 0.56–1.05; p = 0.10). The certainty of evidence was moderate for both outcomes. Subgroup analyses based on baseline vitamin D levels and duration of follow-up yielded consistent results. The incidence of serious adverse events was comparable between the vitamin D and placebo groups (OR: 1.02; 95% CI: 0.76–1.38; p = 0.87), and none of the serious events were attributed to vitamin D supplementation. In conclusion, vitamin D supplementation does not significantly reduce the risk of tuberculosis infection or progression to active tuberculosis, although it is safe and well tolerated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Second Department of Infection, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, Fujian Province, China.
Zitieren
APA
Liu, S., Lin, T., & Pan, Y. (2025). Vitamin D supplementation for tuberculosis prevention: A meta-analysis. Biomolecules and Biomedicine, 26(4), 559-571. https://doi.org/10.17305/bb.2025.12527
Vancouver
Liu S, Lin T, Pan Y. Vitamin D supplementation for tuberculosis prevention: A meta-analysis. Biomolecules and Biomedicine. 2025;26(4):559-571. doi:10.17305/bb.2025.12527
BibTeX
@article{Liu2025,
author = {Liu, Sheng and Lin, Tianyu and Pan, Yanyu},
title = {Vitamin D supplementation for tuberculosis prevention: A meta-analysis},
journal = {Biomolecules and Biomedicine},
year = {2025},
volume = {26},
number = {4},
pages = {559--571},
doi = {10.17305/bb.2025.12527}
}
EUVIMED